New Member to the CCRA Advisory Board
CCRA welcomes Dr. Dajan O’Donnell to its Advisory Board as the representative for the Cancer Research Society, where he serves as the Director of Scientific Affairs and Partnerships. Dajan is a seasoned professional with recent experience at Exactis Innovation and a long tenure in the pharmaceutical industry. He has a PhD in neurology and neurosurgery.
Innovating Against Cancer
The Canadian Partnership Against Cancer is working with partners across Canada to accelerate and introduce programs that will restore and sustain cancer care. Learn more. Read More »
The Canadian Partnership Against Cancer is working with partners across Canada to accelerate and introduce programs that will restore and sustain cancer care. Learn more. Read More »
2018 Investment in Cancer Research: Report Released
Today, CCRA released its latest report on the investment in cancer research. It reveals that $491M was invested in cancer research in 2018. Although a slight increase since 2017 (up $17M), the investment has been fairly constant over the past five years.
This year's report includes some new analyses, which quantify the cancer-... Read More »
Today, CCRA released its latest report on the investment in cancer research. It reveals that $491M was invested in cancer research in 2018. Although a slight increase since 2017 (up $17M), the investment has been fairly constant over the past five years.
This year's report includes some new analyses, which quantify the cancer-... Read More »